Authors: PAGANI O SESSA C VANDENBULCKE T MARTINELLI G ZAMPINO G NOLE F ZIMATORE M LOCATELLI M CRIVELLARI D BUONADONNA A THURLIMANN B HESS D BORNER M BAUER J RIGGI M RIVA A GOLDHIRSCH A

Citation: O. Pagani et al., DOSE-FINDING STUDY OF HIGH-DOSE EPIRUBICIN (E) AND DOCETAXEL (D) AS FIRST-LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC), Annals of oncology, 9, 1998, pp. 74-74

Authors: SESSA C ZUCCHETTI M BAUER J NAEGELE H DINCALCI M GHIELMINI M ROSSI S VANDENBULCKE T PACCIARINI M DOMENIGONI L CAVALLI F

Citation: C. Sessa et al., PHASE-I CLINICAL AND PHARMACOKINETIC (PK) STUDY OF ORAL (PO) METHOXY-MORPHOLINO DOXORUBICIN (PNU-152243) ON A SINGLE INTERMITTENT SCHEDULE, Annals of oncology, 9, 1998, pp. 450-450

Authors: PAGANI O AAPRO M MARTINELLI G BAUER J BORNER M CRIVELLARI D THURLIMANN B VANDENBULCKE T GOLDHIRSCH A

Citation: O. Pagani et al., DOSE-FINDING STUDY OF HIGH-DOSE EPIRUBICIN (E) AND DOCETAXEL (T) AS FIRST LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC), European journal of cancer, 33, 1997, pp. 654-654